home > drugs a-z list > cycloset (bromocriptine mesylate tablets) drug center

Recommended Topic Related To:

Cycloset

Diabetes facts

  • Diabetes is a chronic condition associated with abnormally high levels of sugar (glucose) in the blood.
  • Insulin produced by the pancreas lowers blood glucose.
  • Absence or insufficient production of insulin causes diabetes.
  • The two types of diabetes are referred to as type 1 (insulin dependent) and type 2 (non-insulin dependent).
  • Symptoms of diabetes include increased urine output, thirst and hunger as well as fatigue.
  • Diabetes is diagnosed by blood sugar (glucose) testing.
  • The major complications of diabetes are both acute and chronic.

    • Acutely: dangerously elevated blood sugar, abnormally low blood sugar due to diabetes medications may occur.
    • Chronically: disease of the blood vessels (both small and large) which can damage the eye, kidneys, nerves, and heart may occur

  • Diabetes treatment depends...

Cycloset

font size

Cycloset Drug Center

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Cycloset Prescribing Information: Indications & Dosage

CYCLOSET® (bromocriptine mesylate) Structural Formula Illustration

Type 2 diabetes mellitus

CYCLOSET (bromocriptine mesylate tablets) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Important Limitations of Use

  • CYCLOSET (bromocriptine mesylate tablets) should not be used to treat type 1 diabetes or diabetic ketoacidosis.
  • Limited efficacy data in combination with thiazolidinediones
  • Efficacy has not been confirmed in combination with insulin.

Read the complete drug monograph for Cycloset »

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Diabetes

Find tips and advances in treatment.